Massachusetts General Hospital

Sequencing data provided by Massachusetts General Hospital shows high-levels of in vivo AAV – and worryingly Cas9 – integration into the genome after gene-editing | 9/16/2019

… of the plasmid into the genome, if the episomal hypothesis is incorrect, is under-reported. A recent pre-print [1] has highlighted that bacterial genes from the plasmid were integrated into bovine genomes [2]. Massachusetts General Hospital has recently published data on CRISPR edits (Accid:PRJNA563918), noting ‘high levels of AAV integration (up to 47%) into Cas9-induced double-strand breaks (DSBs)’. However, they do not mention Cas9 integration. Here …

New Supercooling Method Triples Organs Viability for Transplant | 9/14/2019

… can stay viable for transplantation for a couple of hours max. But now, you can expand this time window for more than a whole day thanks to the work of a research team from Massachusetts General Hospital (Mass General) and Harvard Medical School (HMS). Supercooling Way to Extend Donor Organs Shelf Life We need better organ storage protocols than the existing cooling and perfusion processes that can’t keep organs viable …

Follow Massachusetts General Hospital:    

Weekly Meanderings, 14 September 2019 | 9/14/2019

Former Florida State safety Myron Rolle was scheduled to travel Wednesday to the Bahamas to aid in the country’s recovery from Hurricane Dorian, according to the Tallahassee Democrat ‘s Jim Henry . Rolle tweeted Monday he was joining colleagues from Massachusetts General Hospital to provide medical aid: “People have been displaced, it has been difficult getting resources, food, proper medications, basic necessities,” Rolle told Henry. “We will assist with medical needs …

Shahrokh Javaheri: An inspiration in the sleep medicine field and beyond | 9/13/2019

AASM member Dr. Shahrokh Javaheri has inspired many young doctors — his daughter included — and has committed his life to patient care; sleep research; and educating medical students, fellows, sleep technologists, cardiologists, and other sleep doctors. Dr. Sogol Javaheri provides us with insight on her father’s dedication to sleep medicine. Dr. Shahrokh Javaheri was born and raised in Shiraz, Iran, and he attended medical school at the Pahlavi University. He then …

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

September 13, 2019 Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis Author Affiliations Article Information 1 Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 2 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland 3 Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, Massachusetts 4 Department of Neurology, Harvard Medical School …

Outpatient Surgery Market Exploring Future Growth 2019-2025 and Key Players – Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center | 9/13/2019

… through the competitive landscape of the global industry player and helps the companies to garner Outpatient Surgery Market revenue by understanding the strategic growth approaches. Major Key Players of the Outpatient Surgery Market are: Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic , St Jude Children’s Research Hospital , Johns Hopkins Medicine , University of Maryland Medical , Taipei Veterans General Hospital Get sample …

Same-day Surgery Market to Witness Huge Growth from 2019-2025 and Focusing on Top Key Players – Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic | 9/13/2019

… Market revenue by understanding the strategic growth approaches. Major Key Players of the Same-day Surgery Market are: Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic , St Jude Children’s Research Hospital , Johns Hopkins Medicine , University of Maryland Medical , Taipei Veterans General Hospital Get sample copy of “Same-day Surgery Market” at: https://www.reportsweb.com/inquiry&RW00012577396/sample Major Types of Same …

‘Supercool’ method triples organ survival | 9/13/2019

… day, which researchers say could revolutionise organ transplants. The next step will be assessing how long supercooled organs function in large animals such as pigs, before moving to human clinical trials. The team at Massachusetts General Hospital and Harvard Medical School pioneered the technology in rats five years ago. The animal’s tiny livers were chilled while nutrients and oxygen were pumped through the organ’s blood vessels. However, there were challenges …

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer | 9/13/2019

Translational Cancer Mechanisms and Therapy Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer Sophia C. Kamran , Jochen K. Lennerz , Claire A. Margolis , David Liu , Brendan Reardon , Stephanie A. Wankowicz , Emily E. Van Seventer , Adam Tracy , Jennifer Y. Wo , Scott L. Carter , Henning Willers , Ryan B. Corcoran , Theodore S. Hong and Eliezer M. Van Allen Sophia C. Kamran Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School …

Massachusetts General Hospital creates Lancer Endowed Chair of Dermatology | 9/13/2019

… manage your alerts . Harold Lancer, MD, announced the Lancer Endowed Chair of Dermatology at Massachusetts General Hospital, which will recognize the talent, accomplishments and work of Richard Rox Anderson, MD, FAAD, director of the Massachusetts General Hospital Wellman Center for Photomedicine, as its first recipient. The newly created endowed chair will allow for further research into diagnostic and therapeutic techniques and procedures, according to a press release. Lancer is an …

Study Shows Link Between Conversion Therapy and Suicide Attempts | 9/13/2019

… been associated with causing a wide range of mental health issues. In other words, as we already knew, conversion therapy is bad for mental health. The study was done by The Fenway Institute at Massachusetts General Hospital and McLean Hospital. It is one of the first studies that shows an association between exposure to gender identity conversion and metal health outcomes among transgender adults in the U.S. “The rate of …

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit | PR Newswire | 9/12/2019

… measuring it. We must be thoughtful in choosing measures that are relevant to meaningful quality and linked to patient outcomes. Measurements should be easily attainable without adding administrative burdens—ideally by extracting them from electronic health records or cancer registries, rather than by manual chart abstraction—and must be repeatedly measured with an approach geared toward continuous process improvement.” Many panelists wanted to see patient preferences play a much larger …

12 early-career scientists win PROLAB awards | PR Newswire | 9/12/2019

… top cancer research centers in the world.” María José Pascual is a graduate student at the National University of General San Martín in Buenos Aires, Argentina. She will travel to the Stowers Institute for Medical Research in Kansas City, Mo. , to advance her studies of how dengue infection affects tRNA repertoire and mRNA stability of the host cell. Working in the lab of Ariel Bazzini “ will be a completely different …

Trans adults who try professional help to change gender identity are twice likely to commit suicide, new study finds - New York Daily News | 9/12/2019

… a person’s gender identity can have some tragic and lifelong consequences, a new study published Wednesday in the journal JAMA Psychiatry has found. Authored by researchers at The Fenway Institute, and Harvard Medical School’s Massachusetts General Hospital and McLean Hospital, the study links gender identity conversion efforts in U.S. adults to “severe psychological distress.” Advertisement “This is the first study to show that exposure to psychological attempts to change a …

Doctor: Flu season may arrive early this year | WPRI.com | 9/12/2019

Sep 12, 2019 / 06:35 AM EDT / Updated: Sep 12, 2019 / 02:57 PM EDT BOSTON, Mass. (WPRI) — Some doctors are predicting a moderate to severe flu season in the United States, and say it’s not too soon to start thinking about getting a flu shot. Dr. Ali Raja, vice chairman of emergency medicine at Massachusetts General Hospital, says he’s taking cues from other countries flu seasons. “In Australia, the flu season …

Plymouth - a look back: Sept. 11 | 9/12/2019

… are.” Five teenagers, three of them juveniles, were arrested that week by Plymouth police and charged with cottage breaks at Manomet Beach Shores. One 14-year-old was being treated for head injuries at Massachusetts General Hospital because a car in which she was riding had overturned on Route 44 during a police chase. Ten cows, “all good milkers,” were killed by a lightning strike the previous Sunday at the …

‘Justice for Julia’: Fundraisers help teen hit by car | 9/12/2019

Justice for Julia’: Fundraisers help teen hit by car 3:58 PM PORTSMOUTH�� Almost a month after she was seriously injured by a hit-and-run driver, Julia West, 19, remains hospitalized in Boston while friends back home are hosting a fundraiser Saturday, when all are invited. Police say West was walking along Woodbury Avenue at about 1 a.m. Aug. 16 when she was struck by a vehicle and left unconscious …

Conversion therapy poses serious health risks for transgender people, new Boston-based study shows | 9/12/2019

… mental health outcomes, including suicide attempts. The study, “Association Between Recalled Exposure to Gender Identity Conversion Efforts and Suicide Attempts,” was conducted by researchers at The Fenway Institute, and Harvard Medical School researchers at Massachusetts General Hospital and McLean Hospital. “What this new study shows is that transgender people who are exposed to conversion efforts anytime in their lives have more than double the odds of attempting suicide compared with …

Justin P. Croteau joins Fisher Financial, partnering with Ron Theissen | 9/12/2019

Fisher Financial Advisors, a regional New England financial advisory firm, is pleased to announce that Justin P. Croteau has joined its Chester, Vt. team. Justin brings a diverse and deep professional background to Fisher Financial, all with the common theme of outstanding client service. He has worked in marketing and development in higher education and hospitals including Carnegie Mellon University and Massachusetts General Hospital, counseling donors on planned giving. In …

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma | 9/12/2019

… Chris Panzini , Lauren S. Riley , Kathleen Gallagher and Marcela V. Maus Blood 2019 134:860-866; doi: https://doi.org/10.1182/blood.2019001694 Matthew J. Frigault ORCID record for Matthew J. Frigault Jorg Dietrich Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, ORCID record for Mark Leick Bryan D. Choi Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Department of Neurosurgery …

AMA

NIH announces six inaugural Genomic Innovator Awards | National Institutes of Health (NIH) | 8/27/2019

… the frequent use of mouse models around the globe, addressing these challenges may have lasting impact on biomedical research. Eric Gamazon, Ph.D., at Vanderbilt University Medical Center, Nashville, Tennessee, studies the genomic and environmental basis … where they are being cared for. Luca Pinello, Ph.D., at Massachusetts General Hospital, Boston, is interested in disease-associated variants that lie in regions of the genome that do not code for genes. Many of …

Presbyterian Healthcare reports phishing scam exposed 183K patients’ data | FierceHealthcare | 8/27/2019

… to the HHS breach portal that cite email hacking as the reason for the breach. A recent study published in JAMA Network Open found that hospital employees are vulnerable to phishing emails, as 1 in … of several major data breaches reported this week. Last week, Massachusetts General Hospital reported that nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their …

Food and Drug Administration

bluebird bio to Present Data from Clinical Development Program of Lenti-DTM Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the 13th European Pediatric Neurology Society (EPNS) Congress | Business Wire | 9/3/2019

… Transplant in patients with Cerebral Adrenoleukodystrophy (CALD) Presenter: Dr. Florian Eichler, Center for Rare Neurological Diseases, Associate Professor of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA Date & Time (Parallel Session 2D: Neurometabolic Disorders … designation for the treatment of adrenoleukodystrophy (ALD). The United States Food and Drug Administration granted Lenti-D Orphan Drug status for the treatment of ALD, and Rare Pediatric Disease designation and Breakthrough Therapy designation for …

NIH launches novel nationwide search for neuroprotective stroke therapies | National Institutes of Health | 9/3/2019

… protecting the brain before and during clot removal after an ischemic stroke. The therapies have been approved by the U.S. Food and Drug Administration for treating other diseases, such as cancer and multiple sclerosis. All … the effectiveness of the immunosuppressive drug Tacilizumab. Cenk Ayata, M.D. — Massachusetts General Hospital, Boston (NS113443): This group will test the effectiveness of the vasodilator Fasudil. David C. Hess, M.D. — Augusta University, Georgia ( NS113356 ): This group …

ACA

DoseChecker | ZDNet | 8/14/2019

Massachusetts General Hospital, this app is intended for use by physicians and other health care providers who prescribe hydroxychloroquine to their patients or who monitor the ocular effects of this medication on their patients.1. The app uses the Actual Body Weight method, following American Academy of Ophthalmology 2016 guidelines.2. The app uses an adjustable weekly dosing schedule. Instead of placing the patient on either 400 mg per day …

Cohen Veterans Network Partners with Home Base and Mass General Hospital to Provide First-Class Pediatric Assessment Training for the Field | PR Newswire | 8/13/2019

… improving the care of military children around the country via an innovative mental health training partnership with Home Base and Massachusetts General Hospital (MGH). Leveraging the expertise of clinicians from Home Base and MGH’s Psychiatry … access to care. The training curriculum, developed by MGH’s Psychiatry Academy and Home Base, a Red Sox Foundation and Massachusetts General Hospital program, is designed to help providers translate knowledge of best practices for assessment …

National Institutes of Health

NIH announces six inaugural Genomic Innovator Awards | National Institutes of Health (NIH) | 8/27/2019

… approximately $500,000 per year over a five year project period. The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, created the Genomic Innovators Awards in 2018. Unlike more traditional research … where they are being cared for. Luca Pinello, Ph.D., at Massachusetts General Hospital, Boston, is interested in disease-associated variants that lie in regions of the genome that do not code for genes. Many of …

Walking Forward Program Awarded $3 Million Grant to Improve Tribal Cancer Care | Markets Insider | Business Insider | 8/26/2019

National Institutes of Health, for a two-phase study to advance palliative care in Northern Plains American Indians. The funding will allow the two-phase study to bring the Oglala, Sicangu and Cheyenne River tribes, the Great Plains Tribal Chairmen’s Health Board, South Dakota State University’s School of Nursing, the Indian Health Service Great Plains Region and the Rural Health and Palliative Care programs at Massachusetts General Hospital together as …

Clinical Data

Slowing brain rhythms can serve as a marker for delirium and its clinical outcomes | 9/10/2019

Massachusetts General Hospital (MGH) have found. In a paper published in Neurology , the team reported that the generalized slowing of brain rhythms, shown as abnormal theta or delta waveforms on a routine clinical EEG, were associated with longer patient hospitalizations, worse functional outcomes and increased mortality.”There is growing concern that delirium severity is associated with worse prognosis, and our study provides for the first time hard clinical data that …

ACO

Letters to the editor of the Boston Globe Magazine - The Boston Globe | 8/23/2019

Massachusetts General Hospital going toward the bridge. Luckily, no injuries other than a small cut on my hand. Todd S. Kaplan / Somerville I lived in Beacon Hill for more than 40 years. I was nearly injured by cyclists a number of times. If cycling is to continue to pervade Boston, cyclists must comply with the rules of the road, they must have plates on their bikes, and the city must …

MGH reports data breach that exposed information of nearly 10,000 people - The Boston Globe | 8/22/2019

Massachusetts General Hospital said Thursday that a data breach in its neurology department has exposed the private information of nearly 10,000 people. “An unauthorized third party” accessed data in two computer programs used by researchers … in recent years, including: ■ A 2012 breach at Beth Israel Deaconess Medical Center left thousands of patients’ details vulnerable. The hospital later agreed to pay a $100,000 state fine and improve the security of patient

NIH

Chronic graft-versus-host disease of the hair follicular may be a form of alopecia | 9/10/2019

NIH consensus framework should be considered to include new sclerotic or nonscarring alopecia as a diagnostic criterion for [chronic graft-versus-host disease],” Lauren R. Penzi , MD, dermatology at Massachusetts General Hospital, Boston, single-center study included 17 adult allogenic hematopoietic cell transplantation (HCT) recipients who received a diagnosis of cutaneous chronic graft-versus-host disease (cGVHD) at Massachusetts General Hospital in Boston. Two 4 mm punch biopsies of the …

Chronic graft-versus-host disease of the hair follicle may be a form of alopecia | 9/10/2019

NIH consensus framework should be considered to include new sclerotic or nonscarring alopecia as a diagnostic criterion for [chronic graft-versus-host disease],” Lauren R. Penzi , MD, of the department of dermatology at Massachusetts General Hospital, Boston, The single-center study included 17 adult allogenic hematopoietic cell transplantation (HCT) recipients who received a diagnosis of cutaneous chronic graft-versus-host disease (cGVHD) at Massachusetts General Hospital in Boston. Two 4 …

Medicare

Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare | PR Newswire | 8/26/2019

… Care today announced the opening of five practices in North Carolina providing high quality primary care to older adults on Medicare. The locations will open in Fall 2019 with two sites in Charlotte and three … forefront of this vision. She completed a geriatric fellowship at Massachusetts General Hospital. 8332 Pineville Matthews Road, Charlotte, NC , 28226 Grand Opening: October 2 from 10 am - 12 pm Melanie McMinn , MD , is board-certified …

Why insurers Harvard Pilgrim and Tufts want to merge | Modern Healthcare | 8/15/2019

… in the state between Beth Israel Deaconess Medical Center and Lahey Health, which closed in May. Partners, the owner of Massachusetts General Hospital and Brigham and Women’s Hospital, had pursued an acquisition of Care New … eyes on competing with national plans in the employer and Medicare Advantage segment, said Peter Manoogian, a Boston-based partner at ZS, a professional services firm focused on healthcare. “Tufts is very well-known player …

Mental Health

American Foundation for Suicide Prevention Invests $6.2M in Scientific Research to Prevent Tenth Leading Cause of Death | PR Newswire | 9/4/2019

… public education events. Many of the AFSP grantees then go on to receive further funding from the National Institute of Mental Health and other large funding agencies. The 26 grants awarded this year address six … 29,989 Researcher: Alysa Doyle, PhD, Assistant Professor of Psychiatry Location: Massachusetts General Hospital/ Harvard Medical School , Boston, MA The American Foundation for Suicide Prevention is dedicated to saving lives and bringing hope to those affected …

There’s No Such Thing as a ‘Gay Gene,’ a New Study Argues | Yahoo News | 8/30/2019

… say. “Individual-level prediction is not going to be a reality,” says study co-author Benjamin Neale, a geneticist at Massachusetts General Hospital. The study did, however, provide some clues as to how genetics could … found genetic overlap with traits that could predispose people to mental health issues, which are disproportionately common in the LGBTQ community , and to risk-taking behavior, which could theoretically include sexual exploration. About 40% of …

Medicaid

Wentworth-Douglass reduces costs following Mass General merger | 9/9/2019

PORTSMOUTH — Wentworth Douglass Hospital President and CEO Greg Walker said since his hospital merged with Massachusetts General Hospital and its parent company, Partners HealthCare, in 2017 he has observed significant operational cost savings while increasing … because those are some of your high-risk moms; your Medicaid moms, we’ve seen an increase in drug-seeking moms that are delivering babies that are high-risk,” Walker said. “That might not make money

Tuesday, August 27, 2019 | Kaiser Health News | 8/27/2019

… or entry visas to applicants who use — or are deemed likely to use — federally funded food stamps, housing assistance and Medicaid. (Ibarra, 8/27) Seattle Times: Migrant Children Now In Washington State Tell Of Haunting Conditions … after it refused to pay for her $95,000 treatment at Massachusetts General Hospital. The treatment, called proton beam radiation therapy, is designed to precisely target a tumor while protecting the surrounding organs. (Dayal McCluskey, 8/27 …

Biohaven

Biohaven Provides Update On Phase 2/3 Alzheimer’s Disease Clinical Trial: Over 400 Patients Enrolled - NASDAQ.com | 7/22/2019

NEW HAVEN, Conn., July 22, 2019 /PRNewswire/ – Biohaven ) a clinical-stage late-stage neurological and neuropsychiatric diseases, today announced that enrollment in the T2 Protect AD Study, a Phase 2/3 clinical trial of troriluzole in … Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Currently, Biohaven’s lead development programs include multiple compounds across its CGRP receptor antagonist, glutamate modulation and myeloperoxidase inhibition platforms. More information about

Biohaven’s Nurtec (riluzole) 505(b)2 Application for Amyotrophic Lateral Sclerosis Affected by Issues Related to Apotex Plant: Complete Response Letter (CRL) Received From FDA Related to Isolated Drug Substance Supply Used in Bioequivalence Study - NASDAQ.com | 7/20/2019

Biohaven is already engaged with the FDA regarding next steps for a timely resolution of this matter and has submitted additional information to the Agency. -FDA cited issues with the active pharmaceutical ingredient (API) used … Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Currently, Biohaven’s lead development programs include multiple compounds across its CGRP receptor antagonist, glutamate modulation and myeloperoxidase inhibition platforms. More information about

Bristol-Myers Squibb

Global Neoantigen Targeted Therapies Market 2019-2030: Marketed and Development Pipeline, Pipeline Analysis, List of Drug Developers | PR Newswire | 8/6/2019

DUBLIN , Aug. 6, The “Neoantigen Targeted Therapies Market, 2019-2030” report has been added to ResearchAndMarkets.com’s offering. The Neoantigen Targeted Therapies Market, 2019-2030 report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. One of the key objectives of the …

Biohaven Provides Update On Phase 2/3 Alzheimer’s Disease Clinical Trial: Over 400 Patients Enrolled - NASDAQ.com | 7/22/2019

Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Currently, Biohaven’s lead development programs include multiple compounds across its CGRP receptor antagonist, glutamate modulation and myeloperoxidase inhibition platforms. More information about Biohaven is available at www.biohavenpharma.com . About ADCS The Alzheimer’s Disease Cooperative Study (ADCS) at the University of California San Diego is an academic research organization that promotes the discovery and testing of …

Bristol-Myers

Global Neoantigen Targeted Therapies Market 2019-2030: Marketed and Development Pipeline, Pipeline Analysis, List of Drug Developers | PR Newswire | 8/6/2019

DUBLIN , Aug. 6, The “Neoantigen Targeted Therapies Market, 2019-2030” report has been added to ResearchAndMarkets.com’s offering. The Neoantigen Targeted Therapies Market, 2019-2030 report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. One of the key objectives of the …

Biohaven Provides Update On Phase 2/3 Alzheimer’s Disease Clinical Trial: Over 400 Patients Enrolled - NASDAQ.com | 7/22/2019

Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Currently, Biohaven’s lead development programs include multiple compounds across its CGRP receptor antagonist, glutamate modulation and myeloperoxidase inhibition platforms. More information about Biohaven is available at www.biohavenpharma.com . About ADCS The Alzheimer’s Disease Cooperative Study (ADCS) at the University of California San Diego is an academic research organization that promotes the discovery and testing of …

Novartis

Tuesday, August 27, 2019 | Kaiser Health News | 8/27/2019

… six weeks of pregnancy should have included an exception for rape and incest. (Sentell, 8/26) Pharmaceuticals FDA Appeared To Believe Novartis Data Manipulation Issues Had Been Rectified Months Before Public Controversy An FDA said Novartis … after it refused to pay for her $95,000 treatment at Massachusetts General Hospital. The treatment, called proton beam radiation therapy, is designed to precisely target a tumor while protecting the surrounding organs. (Dayal McCluskey, 8/27 …

Easton toddler denied $2.1m gene therapy will now get it for free - The Boston Globe | 8/12/2019

… million medicine to treat her rare genetic disease, after all. Illinois-based AveXis, a subsidiary of the Swiss drug giant Novartis, has agreed to provide Zolgensma, an intravenous gene therapy that requires only one dose … application. But after receiving more documentation from Natalia’s neurologist at Massachusetts General Hospital after the Globe story was published, AveXis concluded the toddler did indeed have the worst form and was entitled to receive Zolgensma …

Pfizer

Hospitals rationing immune disorder drug | Becker’s Hospital Review | 8/10/2019

… life threatening and are saving the treatment for those who need it to stay alive. Manufacturers of immune globulin, including Pfizer and Takeda Pharmaceuticals, say there has been more demand for the drug since it’s … Wheeler, chief of staff at Cininatti Children’s told the Journal. Massachusetts General Hospital in Boston has also canceled many infusion appointments since June because of the shortage. The hospital expects to receive less than half …

Leap Therapeutics Reports Second Quarter 2019 Financial Results | PR Newswire | 8/9/2019

… WEBCAST: On August 6, 2019 , Leap hosted a DKN-01 program update webcast with Samuel J. Klempner , MD, Assistant Professor, Massachusetts General Hospital Cancer Center and Harvard Medical School , and Rebecca C. Arend , MD, Assistant … a global strategic alliance between Merck KGaA, Darmstadt, Germany , and Pfizer Inc., New York, USA . CONTACT: Douglas E. Onsi Chief Financial Officer Leap Therapeutics, Inc. [email protected] 617-714-0360 Argot Partners Investor Relations Heather Savelle 212-600-1902 …

Merck

Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer | Globe Newswire | 8/12/2019

… years of biopharmaceutical experience supporting pipeline development. She was most recently Senior Vice President, Head of Global Clinical Operations, at Merck Serono, a division of Merck KGaA, where she led clinical and development operations toward … for two product approvals. Ms. Ford earned her RN from Massachusetts General Hospital School of Nursing and her BSN from Fitchburg State College. “I’m delighted to be joining Kura at such a critical stage in …

Leap Therapeutics Reports Second Quarter 2019 Financial Results | PR Newswire | 8/9/2019

… WEBCAST: On August 6, 2019 , Leap hosted a DKN-01 program update webcast with Samuel J. Klempner , MD, Assistant Professor, Massachusetts General Hospital Cancer Center and Harvard Medical School , and Rebecca C. Arend , MD, Assistant … occurrence of unanticipated events. KEYTRUDA ® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ , USA. BAVENCIO ® is a registered trademark of Merck KGaA, Darmstadt, Germany , and is …

Genentech

Global Neoantigen Targeted Therapies Market 2019-2030: Marketed and Development Pipeline, Pipeline Analysis, List of Drug Developers | PR Newswire | 8/6/2019

… European Investment Bank Evaxion Biotech F-Prime Capital Fidelity Investments Flow Pharma Forbion Foresite Capital Franklin Advisers Frazier Healthcare Partners Genentech Geneos Therapeutics Genocea Biosciences Georgetown University GlobeImmune Google Ventures Gradalis Grey Wolf Therapeutics Gritstone … Level One Partners Likang Life Sciences Lilly Asia Ventures LSP Massachusetts General Hospital MaSTherCell Mateon Therapeutics Max Delbrck Center for Molecular Medicine in the Helmholtz Association MD Anderson Cancer Center Medigene MedImmune Meir Medical Center …

Immune Therapy A Great Tool, But Limitations Exist | WebMD | 6/13/2019

… tumors. Breast cancer had been looking even more promising. In March, the FDA approved checkpoint inhibitor Tecentriq, from biotech company Genentech, to treat metastatic triple-negative breast cancer, which is often lethal. But in one … checkpoint inhibitors, say Keith Flaherty, MD, a melanoma specialist at Massachusetts General Hospital in Boston. Roughly another third of melanoma patients get great early results, but then the drugs stop working, Flaherty says. The tumor …

IM Health

Why insurers Harvard Pilgrim and Tufts want to merge | Modern Healthcare | 8/15/2019

Healthcare policy and antitrust experts doubt the proposed union of Massachusetts-based health insurers Harvard Pilgrim Health Care and Tufts Health Plan would benefit patients in any way, despite the insurers’ promises of lower costs … Lahey Health, which closed in May. Partners, the owner of Massachusetts General Hospital and Brigham and Women’s Hospital, had pursued an acquisition of Care New England until it dropped its bid in June. “They may

Myechia Minter-Jordan to Join DentaQuest as Chief Impact Officer | Business Wire | 7/15/2019

… Pilgrim Health Care and The Boston Foundation, on the President’s Council of Massachusetts General Hospital and on advisory boards for the Boston Children’s Museum, the YMCA and WBUR. “I am thrilled to be joining the DentaQuest team,” said Jordan. “I look forward to bringing my experience in caring for vulnerable populations in an integrated and holistic manner to an organization that is serious about incorporating oral health into overall health …

Celgene

Global Neoantigen Targeted Therapies Market 2019-2030: Marketed and Development Pipeline, Pipeline Analysis, List of Drug Developers | PR Newswire | 8/6/2019

… Caladrius Biosciences California Technology Ventures Canaan Investment Cancer Prevention and Research Institute of Texas Cancer Research Technology Casdin Capital Catalent Celgene Cellular Biomedicine Charles River Laboratories Chartwave Children’s Hospital of Orange County China Medical System … Level One Partners Likang Life Sciences Lilly Asia Ventures LSP Massachusetts General Hospital MaSTherCell Mateon Therapeutics Max Delbrck Center for Molecular Medicine in the Helmholtz Association MD Anderson Cancer Center Medigene MedImmune Meir Medical Center …

Chutes & Ladders—Novartis says hello to new pharma chief | FierceMedicalDevices | 6/13/2019

… CEO Olivier Brandicourt , Novartis lost its pharma chief, Paul Hudson . But Tschudin, who joined the company in January 2017 from Celgene, will take the baton and become one of the most highly placed women in … Cancers, the Paula O’Keeffe Endowed Chair of Thoracic Oncology at Massachusetts General Hospital, co-leader of the Dana-Farber/MGH/Harvard Cancer Center Thoracic Oncology Program and a professor of medicine at Harvard Medical School …

GE Healthcare

NVIDIA, American College of Radiology Partner to Accelerate AI for Diagnostic Radiology | HIT Consultant | 4/9/2019

… to build, share, locally adapt and validate AI algorithms, while also ensuring patient data stays protected at the local institution. GE Healthcare, Nuance, and NVIDIA, along with a vast network of healthcare startups and research … initial pilot with the Ohio State University (OSU) and the Massachusetts General Hospital and Brigham and Women’s Hospital’s Center for Clinical Data Science (CCDS) helped NVIDIA and ACR define the assets and pathways necessary to …

Nvidia wants AI Clara to be the AI platform for radiologists | VentureBeat | 4/8/2019

… more machine learning into their work. The move follows a three-month pilot assessment program at Ohio State University (OSU), Massachusetts General Hospital, and Brigham and Women’s Hospital’s Center for Clinical Data Science (CCDS). The … workstations and servers for major health care companies and institutions. GE Healthcare and Nuance are also participating in the creation of the ACR AI-LAB for building and sharing AI models for radiologists. The ACR …

Polaris Partners

Shiseido Acquires Breakthrough Technology from Olivo Laboratories | Business Wire | 1/12/2018

… Shiseido Americas Corporation (“Shiseido Americas”), has acquired substantially all of the assets of Olivo Laboratories, LLC (“Olivo”). Olivo is a Polaris Partners-backed Massachusetts-based startup advancing the dermatological field through proprietary biomaterials technology, including … Rox Anderson, Head of the Wellman Center of Photomedicine at Massachusetts General Hospital, and Dr. Dan Anderson, Associate Professor of Chemical Engineering at Massachusetts Institute of Technology. The Olivo research and development team will join …

MPM Capital

Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement to Utilize ElevateBio BaseCamp to Manufacture Innovative Cell and Gene Therapies | Business Wire | 7/25/2019

BOSTON & CAMBRIDGE, Mass.- Massachusetts General Hospital (MGH) and ElevateBio, a cell and gene therapy holding company, today announced that they have entered into a 10-year alliance agreement. The agreement provides MGH preferred access to … investors are the UBS Oncology Impact Fund (OIF) managed by MPM Capital, as well as F2 Ventures. Investors also include EcoR1 Capital, Redmile Group, and Samsara BioCapital. ElevateBio has established ElevateBio BaseCamp, a single R

Atlas Venture

Harvard Business School Announces $10 Million Gift Renewal from the Blavatnik Family Foundation and Introduces 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship | PR Newswire | 6/6/2019

… for his generous and continuous support of the Fellowship,” said Peter Barrett , PhD, senior fellow at HBS and partner at Atlas Venture, who directs the Blavatnik Fellowship with support from a Key Advisory Board of … and mergers and acquisitions. While completing her residency internship at Massachusetts General Hospital, she was named 40 under 40 for health care innovation by MedTech Boston and published in The Atlantic and The Journal of …

Harvard Business School Announces $10 Million Gift Renewal from the Blavatnik Family Foundation and Introduces 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship | Markets Insider | Business Insider | 6/6/2019

… for his generous and continuous support of the Fellowship,” said Peter Barrett , PhD, senior fellow at HBS and partner at Atlas Venture, who directs the Blavatnik Fellowship with support from a Key Advisory Board of … and mergers and acquisitions. While completing her residency internship at Massachusetts General Hospital, she was named 40 under 40 for health care innovation by MedTech Boston and published in The Atlantic and The Journal of …

Versant Ventures

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer | PR Newswire | 7/3/2019

… will be invaluable.” Dr. Tu is a graduate of Harvard Medical School. He completed his medical and cardiology training at Massachusetts General Hospital and Beth Israel Deaconess Medical Center. He is board-certified in cardiology … device incubator. The company is backed by Gilde Healthcare ( www.gildehealthcare.com ), Versant Ventures ( www.versantventures.com ) and U.S. Venture Partners ( www.usvp.com ). For more information, please visit www.inarimedical.com . Contact Tara Dunn , Vice President Clinical Affairs [email protected] SOURCE Inari …

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer | Markets Insider | Business Insider | 7/2/2019

… will be invaluable.” Dr. Tu is a graduate of Harvard Medical School. He completed his medical and cardiology training at Massachusetts General Hospital and Beth Israel Deaconess Medical Center. He is board-certified in cardiology … device incubator. The company is backed by Gilde Healthcare (www.gildehealthcare.com), Versant Ventures (www.versantventures.com) and U.S. Venture Partners (www.usvp.com). For more information, please visit www.inarimedical.com. Contact Tara Dunn , Vice President Clinical Affairs [email protected] View original …

Lightstone Ventures

Harvard Business School Announces $10 Million Gift Renewal from the Blavatnik Family Foundation and Introduces 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship | Markets Insider | Business Insider | 6/6/2019

… Fortune 500 clients in technology and telecommunications across strategy, operations, and mergers and acquisitions. While completing her residency internship at Massachusetts General Hospital, she was named 40 under 40 for health care innovation by MedTech … access to malaria diagnosis and treatment. She has experience at Lightstone Ventures, an early stage life sciences fund. Laura received a BA from Rice University , an MPH from Columbia University , and an MBA from HBS …

Third Rock Ventures

For biotech industry, a milestone: Vertex names woman as president, CEO - The Boston Globe | 7/25/2019

… right person for the role.” Advertisement Kewalramani’s promotion is impressive. Her career path has taken her from physician resident at Massachusetts General Hospital to senior positions at the California biotech giant Amgen to Vertex, which … this is entirely within reach.” Abbie Celniker, a partner at Third Rock Ventures in Boston, which invests in biotech companies, said she has seen three trends develop since the MassBio report came out in 2017 …

New Data Published in Journal Cell Show Robust Mobilization of Highly Engraftable Stem Cells in Mouse Models with Combination of GROβ and Plerixafor | Business Wire | 12/8/2017

… announced the publication of research led by Jonathan Hoggatt, Ph.D., assistant professor of medicine at Harvard Medical School and the Massachusetts General Hospital (MGH) Cancer Center and Center for Transplantation Sciences, and a principal faculty … marrow transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit www.magentatx.com . Contacts Magenta Therapeutics: Manisha Pai, 857-242-1155 Vice …

Partners Innovation Fund

Alizé Pharma 3 raises 67n mln euros | PE Hub | 7/31/2019

… raised 67 million euros ($75 million) in a Series A round led by LSP . Novo Ventures , Kurma Partners , Orbimed , Pontifax, Partners Innovation Fund and Innobio 2 (managed by Bpifrance) participated in the round. Existing shareholders … for the treatment of hypoparathyroidism, that was licensed from the Massachusetts General Hospital in Boston. The unique pharmacological profile of AZP-3601, and its specific actions on calcium metabolism, make it a potential best-in …

Akouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza | PR Newswire | 11/30/2017

… Eye and Ear and Lonza - Akouos raises $7.5 million in equity financing from 5AM Ventures, New Enterprise Associates (NEA), and Partners Innovation Fund.- Massachusetts Eye and Ear and Lonza grant Akouos exclusive licenses to proprietary … Ph.D., Chief of Otolaryngology at Massachusetts Eye and Ear and Massachusetts General Hospital and the Walter Augustus LeCompte Professor and Chair of Otolaryngology at Harvard Medical School and Joan W. Miller , M.D., Chief of Ophthalmology …

Massachusetts General Physicians Organization

Imaging system helps surgeons remove tiny ovarian tumors | Phys Org | 4/24/2019

… small and widespread, it is difficult to eradicate all of them. Researchers at MIT, working with surgeons and oncologists at Massachusetts General Hospital (MGH), have now developed a way to improve the accuracy of this … gynecologic oncologist at MGH and chief medical officer of the Massachusetts General Physicians Organization. Glowing tumors Because there is no good way to detect early-stage ovarian cancer, it is one of the most difficult …

Dr. Timothy Ferris, Chairman and CEO of Massachusetts General Physicians Organization, Joins Health Catalyst Board | PR Newswire | 1/23/2018

Dr. Timothy Ferris, Chairman and CEO of Massachusetts General Physicians Organization, Joins Health Catalyst Board News provided by 07:55 ET Share this article SALT LAKE CITY Health Catalyst , a leader in healthcare analytics, decision support … medical group of nearly 2,500 physicians affiliated with 999-bed Massachusetts General hospital in Boston. Dr. Ferris was previously the medical director of the MGPO, and the senior vice president for Population Health at both

Maxim Group

CURE Pharmaceutical Expands Board with Two Women Directors | Globe Newswire | 8/7/2019

Maxim Group. Previously, Dr. Chung was a co-founder of Tokum Capital, a global healthcare fund, which merged with Perella Weinberg Partners. Prior to that, Dr. Chung managed healthcare investment portfolios at RBR Capital, Kingdon Capital, and Pequot Capital. Earlier in her career, Dr. Chung was a recognized research scientist conducting cutting-edge research in the field of Alzheimer’s disease and Angelman Syndrome at Massachusetts General Hospital/Harvard Medical School …

CURE Pharmaceutical Expands Board with Two Women Directors | Markets Insider | Business Insider | 8/7/2019

Maxim Group. Previously, Dr. Chung was a co-founder of Tokum Capital, a global healthcare fund, which merged with Perella Weinberg Partners. Prior to that, Dr. Chung managed healthcare investment portfolios at RBR Capital, Kingdon Capital, and Pequot Capital. Earlier in her career, Dr. Chung was a recognized research scientist conducting cutting-edge research in the field of Alzheimer’s disease and Angelman Syndrome at Massachusetts General Hospital/Harvard Medical School …

ARCH Venture Partners

Cell Encapsulation Markets 2019-2023: Current Market Landscape and the Future Potential of Encapsulated Cell Therapies and Affiliated Technologies | PR Newswire | 5/29/2019

… Therapeutics Alsace BioValley Altor BioScience ALTuCELL AlzeCure Pharma Amgen Amphera AMVALOR Anhui Kedgene Biotechnology ANI Pharmaceuticals Anterogen apceth Biopharma Arbele ARCH Venture Partners Argos Therapeutics Asahi Glass Company ASAP Ventures Asset Management Partners Astellas Institute … Maine Medical Center Marino Biotechnology Marker Therapeutics Maryland Technology Development Massachusetts General Hospital Massachusetts Institute of Technology MaSTherCell MaxCyte MaxiVAX Mayo Clinic McGill University MED-EL Medeor Therapeutics Medical University of South Carolina Medicyte MediGene …

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV | Business Wire | 5/7/2019

… Keith Joung, M.D., Ph.D. The $58.5 million Series A financing was led by GV (formerly Google Ventures), with participation from ARCH Venture Partners, F-Prime Capital, and Biomatics Capital. The funds raised will be used … is currently director of the Center for Genomic Medicine at Massachusetts General Hospital (MGH), co-director of the Program in Medical and Population Genetics at the Broad Institute, and professor of medicine at Harvard Medical …

Harvard Medical School

New Supercooling Method Triples Organs Viability for Transplant | 9/14/2019

Massachusetts General Hospital (Mass General) and Harvard Medical School (HMS). Supercooling Way to Extend Donor Organs Shelf Life We need better organ storage protocols than the existing cooling and perfusion processes that can’t keep organs viable long enough until they’re transplanted into another body. Kept on ice , at 4 degrees Celsius, donor organs usually have an average of nine hours before cells start falling for irreparable ischemic damage . Compared to …

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

Harvard Medical School, Boston, Massachusetts 5 Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts 6 Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 7 Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 8 Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 13, 2019. doi:10.1001/jamaneurol.2019.3238 How long is the prodromal …

HCA

Presbyterian Healthcare reports phishing scam exposed 183K patients’ data | FierceHealthcare | 8/27/2019

New Mexico-based Presbyterian Healthcare Services notified 183,000 patients and health plan members their protected health information may have been exposed during a phishing attack targeting the email accounts of some employees. The health system … of several major data breaches reported this week. Last week, Massachusetts General Hospital reported that nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their

Partners HealthCare

John H. McArthur, driving force behind creation of Partners, dies | Becker’s Hospital Review | 8/26/2019

John H. McArthur, a former dean of Harvard Business School in Boston and founding co-chair of Boston-based Partners HealthCare, died Aug. 20 at the age of 85. Mr. McArthur, who was born in … major role in driving the hospital’s merger with Boston-based Massachusetts General Hospital, which led to the creation of Partners HealthCare. Mr. McArthur was the founding co-chair of Partners. He received several honors over

John H. McArthur, who led Harvard Business School and helped found Partners, dies at 85 - The Boston Globe | 8/25/2019

… Business School and was credited with being the driving force behind the 1994 merger of Brigham and Women’s Hospital and Massachusetts General Hospital. (Harvard University) Soon after being named the seventh dean of Harvard Business … Hospital and Massachusetts General Hospital and of subsequently helping launch Partners HealthCare, which he served as founding cochairman. Advertisement “The health care system in Boston is, in some ways, John’s creation,” said Nitin Nohria, current …

Mayo Clinic

Outpatient Surgery Market Exploring Future Growth 2019-2025 and Key Players – Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center | 9/13/2019

Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic , St Jude Children’s Research Hospital , Johns Hopkins Medicine , University of Maryland Medical , Taipei Veterans General Hospital Get sample copy of “Outpatient Surgery Market” at: https://www.reportsweb.com/inquiry&RW00012577392/sample Major Types of Outpatient Surgery covered are: Gastrointestinal …

Same-day Surgery Market to Witness Huge Growth from 2019-2025 and Focusing on Top Key Players – Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic | 9/13/2019

Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic , St Jude Children’s Research Hospital , Johns Hopkins Medicine , University of Maryland Medical , Taipei Veterans General Hospital Get sample copy of “Same-day Surgery Market” at: https://www.reportsweb.com/inquiry&RW00012577396/sample Major Types of Same-day Surgery covered are: Gastrointestinal …

Cleveland Clinic

Same-day Surgery Market to Witness Huge Growth from 2019-2025 and Focusing on Top Key Players – Mayo Clinic , Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic | 9/13/2019

Massachusetts General Hospital , Mount Sinai Hospital , New York Presbyterian , University of Washington Medical Center , Cleveland Clinic , St Jude Children’s Research Hospital , Johns Hopkins Medicine , University of Maryland Medical , Taipei Veterans General Hospital Get sample copy of “Same-day Surgery Market” at: https://www.reportsweb.com/inquiry&RW00012577396/sample Major Types of Same-day Surgery covered are: Gastrointestinal …

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit | PR Newswire | 9/12/2019

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH ; City of Hope National Medical Center, Duarte, CA ; Dana - Farber /Brigham and Women’s Cancer Center Massachusetts General Hospital Cancer Center, Boston, MA ; Duke Cancer Institute, Durham, NC ; Fox Chase Cancer Center, Philadelphia, PA ; Huntsman Cancer Institute at the University of Utah , Salt Lake City, UT ; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA ; The Sidney Kimmel Comprehensive Cancer Center at …

Beth Israel Deaconess Medical Center

MGH reports data breach that exposed information of nearly 10,000 people - The Boston Globe | 8/22/2019

Massachusetts General Hospital said Thursday that a data breach in its neurology department has exposed the private information of nearly 10,000 people. “An unauthorized third party” accessed data in two computer programs used by researchers … area hospitals in recent years, including: ■ A 2012 breach at Beth Israel Deaconess Medical Center left thousands of patients’ details vulnerable. The hospital later agreed to pay a $100,000 state fine and improve the security

Why insurers Harvard Pilgrim and Tufts want to merge | Modern Healthcare | 8/15/2019

Beth Israel Deaconess Medical Center and Lahey Health, which closed in May. Partners, the owner of Massachusetts General Hospital and Brigham and Women’s Hospital, had pursued an acquisition of Care New England until it dropped its bid in June. “They may hope by merging they can gain leverage over hospitals, doctors, and drug companies,” Sager said. Tufts and Harvard Pilgrim are likely hoping to compete with the dominant local Blues …

Brigham and Women's Hospital

Promising Clinical Data from Pilot Study of Gelesis’ Novel Hydrogel GS500 Prototype for the Potential Treatment of Chronic Constipation Presented at Digestive Disease Week by Researchers from Massachusetts General Hospital and Brigham and Women’s Hospital | Benzinga | 5/19/2019

Investigational candidate developed by Gelesis demonstrated significant 16 hour reduction in colonic transit time in patients with chronic idiopathic constipation First clinical study demonstrating super-absorbent hydrogel platform’s potential in this common condition Gelesis , a biotechnology company at the forefront of developing mechanobiology-based therapies to treat chronic diseases related to the gastrointestinal (GI) system, announced the presentation of data from a clinical study demonstrating that GS500 prototype (GS500/CSP01 …

Alzheimer’s Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer’s Disease - NASDAQ.com | 5/14/2019

Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School. “The A3 and A45 Studies should provide critically important answers about the optimal time to intervene with anti-amyloid therapy, with the hope that starting treatment much earlier in the disease process may be advantageous in preventing future cognitive decline,” said Dr. Sperling, Director, Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital and co-Principal Investigator …

MD Anderson Cancer Center

U.S. News Releases 30th Annual 2019-20 Best Hospitals Rankings | PR Newswire | 7/30/2019

Massachusetts General Hospital ranked No. 2, followed by Johns Hopkins Hospital at No. 3. The Honor Roll is a distinction awarded to hospitals ranked in the top 20 for delivering exceptional treatment across multiple areas of care. In the specialty rankings , University of Texas MD Anderson Cancer Center ranked No. 1 in cancer , the Cleveland Clinic is No. 1 in cardiology & heart surgery and Hospital for Special Surgery is No …

U.S. News Releases 30th Annual 2019-20 Best Hospitals Rankings | Markets Insider | Business Insider | 7/30/2019

Massachusetts General Hospital ranked No. 2, followed by Johns Hopkins Hospital at No. 3. The Honor Roll is a distinction awarded to hospitals ranked in the top 20 for delivering exceptional treatment across multiple areas of care. In the specialty rankings , University of Texas MD Anderson Cancer Center ranked No. 1 in cancer , the Cleveland Clinic is No. 1 in cardiology & heart surgery and Hospital for Special Surgery is No …

Memorial Sloan Kettering Cancer Center

Doctors at NYU Langone Hospital-Brooklyn Help Patient with Rare Stomach Cancer Turn His Life Around | PR Newswire | 8/13/2019

Memorial Sloan Kettering Cancer Center and conducted postdoctoral research at Harvard Medical School and Massachusetts General Hospital on rare cancers of the digestive system. “We were able to completely remove the tumor, and he has been recovering exceptionally well without chemotherapy or radiation.” Advances in Complex Cancer Detection The gastroenterology team at NYU Langone Hospital–Brooklyn, led by Adam Goodman , MD , had first discovered and diagnosed Battaglia’s cancer following months …

U.S. News Releases 2019-2020 Top Hospitals List | WebMD | 7/30/2019

Top Five for Cardiology and Heart Surgery 1. Cleveland Clinic, Ohio 2. Mayo Clinic, Rochester, MN 3. Cedars-Sinai Medical Center, Los Angeles 4. New York-Presbyterian Hospital/Columbia and Cornell, New York City 5. Massachusetts General Hospital, Boston Top Five for Cancer 1. University of Texas MD Anderson Cancer Center, Houston 2. Memorial Sloan Kettering Cancer Center, New York City 3. Mayo Clinic, Rochester, MN 4. Johns Hopkins Hospital …

Memorial Sloan Kettering

Doctors at NYU Langone Hospital-Brooklyn Help Patient with Rare Stomach Cancer Turn His Life Around | PR Newswire | 8/13/2019

Memorial Sloan Kettering Cancer Center and conducted postdoctoral research at Harvard Medical School and Massachusetts General Hospital on rare cancers of the digestive system. “We were able to completely remove the tumor, and he has been recovering exceptionally well without chemotherapy or radiation.” Advances in Complex Cancer Detection The gastroenterology team at NYU Langone Hospital–Brooklyn, led by Adam Goodman , MD , had first discovered and diagnosed Battaglia’s cancer following months …

Global Neoantigen Targeted Therapies Market 2019-2030: Marketed and Development Pipeline, Pipeline Analysis, List of Drug Developers | PR Newswire | 8/6/2019

Massachusetts General Hospital MaSTherCell Mateon Therapeutics Max Delbrck Center for Molecular Medicine in the Helmholtz Association MD Anderson Cancer Center Medigene MedImmune Meir Medical Center Memorial Sloan Kettering Cancer Center Merck Meusinvest Mie University Miller Value Partners Miracle Light Incubator Moderna Therapeutics Moffitt Cancer Center Morningside Group MSD Partners NantBioScience NantCell NantWorks Natera National Institutes of Health Natixis NEC Nektar Therapeutics Neon Therapeutics NeoPhore Netherlands Cancer Institute NexImmune Nextech Invest …

Harvard Pilgrim Health Care

Myechia Minter-Jordan to Join DentaQuest as Chief Impact Officer | Business Wire | 7/15/2019

Harvard Pilgrim Health Care and The Boston Foundation, on the President’s Council of Massachusetts General Hospital and on advisory boards for the Boston Children’s Museum, the YMCA and WBUR. “I am thrilled to be joining the DentaQuest team,” said Jordan. “I look forward to bringing my experience in caring for vulnerable populations in an integrated and holistic manner to an organization that is serious about incorporating oral health into overall …

New Partners chief no stranger to role of uniter - The Boston Globe | 6/27/2019

As a physician at Massachusetts General Hospital in the 1980s, Dr. Anne Klibanski conceived of a new approach to help patients with pituitary gland disorders. She launched a clinic where a team of specialists — endocrinologists … considering an acquisition of one of Massachusetts’ largest health insurers, Harvard Pilgrim Health Care . Tensions and disagreements about strategy grew under Torchiana’s leadership, and in January he announced that he would step down. Klibanski, 68

Aetna

Promise and cost clash in disputed proton cancer treatment - The Boston Globe | 5/4/2019

… the vital organs nearby. Weissman’s health insurer didn’t agree. Three years ago, as she began preparing for the treatment at Massachusetts General Hospital she thought would save her life, UnitedHealthcare refused to cover the $95,000 … million to the husband of a woman who alleged that Aetna improperly denied coverage for her treatment. The patient, who died in 2015, paid more than $92,000 for proton therapy at MD Anderson Cancer Center …

Memorial Health in South Florida earns top brand ranking | Modern Healthcare | 4/29/2019

… new report ranking health system brands gave the top three spots, in descending order, to Memorial Healthcare System, Hollywood , Fla., Massachusetts General Hospital in Boston and Johns Hopkins Medicine in Baltimore. The announcement comes in … The report notes that if disrupters like Parsley Health, CVS-Aetna , Forward and Haven Healthcare had been included in the rankings, they would have beat every health system on every facet of experience. Wartell said …

Blue Cross Blue Shield Of Massachusetts

New Harvard Medical School Study Finds Blue Cross Blue Shield of Massachusetts Alternative Quality Contract Slowed Spending, Improved Care Over 8 Years | PR Newswire | 7/18/2019

BOSTON , July 17, Blue Cross Blue Shield of Massachusetts ‘ Alternative Quality Contract slowed the rate of medical spending growth by up to 12% while improving patient care over the course of eight years, Harvard Medical … health care policy and medicine at Harvard Medical School and Massachusetts General Hospital, and the study’s leading researcher. “It has helped change the rates that physicians order tests and some imaging modalities, the rates of

Promise and cost clash in disputed proton cancer treatment - The Boston Globe | 5/4/2019

… the vital organs nearby. Weissman’s health insurer didn’t agree. Three years ago, as she began preparing for the treatment at Massachusetts General Hospital she thought would save her life, UnitedHealthcare refused to cover the $95,000 … guided by data, experience, and investigation.” Among private health insurers, Blue Cross Blue Shield of Massachusetts appears to have one of the more generous policies for proton therapy. Company officials said they make coverage decisions …

UnitedHealthcare

Insurer that denied cancer treatment asks for dismissal of Boston woman’s lawsuit - The Boston Globe | 8/27/2019

The country’s largest health insurer is seeking to toss a federal lawsuit that alleges it wrongly denied coverage for a controversial radiation treatment to a Boston woman with cervical cancer. Kate Weissman sued UnitedHealthcare earlier this year after it refused to pay for her $95,000 treatment at Massachusetts General Hospital. The treatment, called proton beam radiation therapy, is designed to precisely target a tumor while protecting the surrounding organs. Weissman …

After Insurers’ Denial, Woman’s Family Paid For $95,000 Cancer Treatment She Believes Saved Her Life. Her Case Against UnitedHealthcare Marches On. | Kaiser Health News | 8/27/2019

UnitedHealthcare earlier this year after it refused to pay for her $95,000 treatment at Massachusetts General Hospital. The treatment, called proton beam radiation therapy, is designed to precisely target a tumor while protecting the surrounding organs. (Dayal McCluskey, 8/27) Des Moines Register: Company Tried To Cut Off Health Insurance When Worker Needed It Most The company told him after a heart attack and open-heart surgery that his health insurance …

Humana

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit | PR Newswire | 9/12/2019

… Quality Measurement, Centers for Medicare and Medicaid Services (CMS) ; Bryan Loy , MD, MBA, Physician Lead – Oncology, Laboratory, and Personalized Medicine, Humana ; Jim Martineau , MBA, Director, Product Management & Operations, Flatiron ; Alexandra Chong , PhD, OCM Team Lead … Center, Duarte, CA ; Dana - Farber /Brigham and Women’s Cancer Center Massachusetts General Hospital Cancer Center, Boston, MA ; Duke Cancer Institute, Durham, NC ; Fox Chase Cancer Center, Philadelphia, PA ; Huntsman Cancer Institute at the University of …

Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare | PR Newswire | 8/26/2019

… onsite labs and 24/7 access to doctors by phone for urgent needs. Iora Primary Care is welcoming patients with UnitedHealthcare, Humana and Blue Cross Blue Shield of North Carolina Medicare Advantage plans as well as … forefront of this vision. She completed a geriatric fellowship at Massachusetts General Hospital. 8332 Pineville Matthews Road, Charlotte, NC , 28226 Grand Opening: October 2 from 10 am - 12 pm Melanie McMinn , MD , is board-certified …

Health Net

New Board Members Elected for the International Photodynamic Association | Globe Newswire | 7/11/2019

… LaserLab, University of Coimbra, Portugal Tayyaba Hasan, PhD (past President) Professor of Dermatology, Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, USA Carolyn Cross, CFA (Treasurer) Chairman and Chief Executive Officer, Ondine Biomedical … Lilge, PhD (Board Member) Senior Scientist, Princess Margaret Hospital; University Health Network Professor, University of Toronto, Canada Girgis Obaid, PhD (Board Member) Research Fellow, Wellman Center for Photomedicine, Massachusetts General Hospital, USA Imran Rizvi, PhD …

New Board Members Elected for the International Photodynamic Association | Markets Insider | Business Insider | 7/10/2019

… LaserLab, University of Coimbra, Portugal Tayyaba Hasan, PhD (past President) Professor of Dermatology, Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, USA Carolyn Cross, CFA (Treasurer) Chairman and Chief Executive Officer, Ondine Biomedical … Lilge, PhD (Board Member) Senior Scientist, Princess Margaret Hospital; University Health Network Professor, University of Toronto, Canada Girgis Obaid, PhD (Board Member) Research Fellow, Wellman Center for Photomedicine, Massachusetts General Hospital, USA Imran Rizvi, PhD …

Healthspan

New Book Explores How Digital Technologies Can Transform Aging And Extend The Healthspan, From Connected Health Visionary Dr. Joe Kvedar | PR Newswire | 10/25/2017

Worldwide Offices New Book Explores How Digital Technologies Can Transform Aging And Extend The Healthspan, From Connected Health Visionary Dr. Joe Kvedar National poll measuring public perception of aging reveals the majority of people believe … Partners HealthCare-affiliated hospitals, including Brigham and Women’s Hospital and Massachusetts General Hospital, community and specialty hospitals, community health centers, home care and other health-related entities. Dr. Kvedar, internationally recognized as a pioneer and

David Ortiz

David Ortiz hires ex-Boston police commissioner - CNN | 8/26/2019

CNN) David Ortiz has hired former Boston Police Commissioner Ed Davis to investigate his shooting at a Dominican nightclub in June, according to a Monday statement from the former Red Sox slugger’s spokesman. Ortiz hired … care June 22, almost two weeks after he was shot. Massachusetts General Hospital released Ortiz last month. Big Papi called his doctors, nurses and caregivers “some of the best teammates I have ever had.” On

Vlad Coric

Biohaven’s Nurtec (riluzole) 505(b)2 Application for Amyotrophic Lateral Sclerosis Affected by Issues Related to Apotex Plant: Complete Response Letter (CRL) Received From FDA Related to Isolated Drug Substance Supply Used in Bioequivalence Study - NASDAQ.com | 7/20/2019

… property licensed from companies and institutions including Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Currently, Biohaven’s lead development programs include multiple compounds across its CGRP receptor … except as required by law. For further information, contact: Dr. Vlad Coric, Chief Executive Officer, [email protected] View original content to download multimedia: http://www.prnewswire.com/news-releases/biohavens-nurtec-riluzole-505b2-application-for-amyotrophic-lateral …

Fred Hutchinson

Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project. | National Institutes of Health | 8/1/2019

… Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts. 8 Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. 9 Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and … California. 24 Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. 25 Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina. 26 Department of Epidemiology …

NCCN and AstraZeneca Support Quality Improvements for Lung Cancer Care | PR Newswire | 5/31/2019

Massachusetts General Hospital Cancer Center, Boston, MA ; Duke Cancer Institute, Durham, NC ; Fox Chase Cancer Center, Philadelphia, PA ; Huntsman Cancer Institute at the University of Utah , Salt Lake City, UT ; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins , Baltimore, MD ; Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ …

Tanuja Chitnis

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for | PR Newswire | 12/18/2017

Tanuja Chitnis , Director of the Partners Pediatric Multiple Sclerosis Center, Massachusetts General Hospital, Boston , US, and Scientist, Ann Romney Center, Brigham and Women’s Hospital, Boston , US. “Children with MS differ from adults in important ways and additional treatment options for pediatric patients are needed,” added Dr. Chitnis, who also served as principal investigator for the PARADIGMS study. The FDA grants Breakthrough Therapy designation for therapies that are intended to treat …

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS | PR Newswire | 12/18/2017

Tanuja Chitnis , Director of the Partners Pediatric Multiple Sclerosis Center, Massachusetts General Hospital, Boston , US, and Scientist, Ann Romney Center, Brigham and Women’s Hospital, Boston , US. “Children with MS differ from adults in important ways and additional treatment options for pediatric patients are needed,” added Dr. Chitnis, who also served as principal investigator for the PARADIGMS study. The FDA grants Breakthrough Therapy designation for therapies that are intended to treat …

Robert W. Carlson

NCCN Advances Cancer Research and Oncology Career Development with Young Investigator Awards, Poster Presentations, and Fellows Program | PR Newswire | 5/8/2019

… to our poster presenters and fellows, NCCN recognizes our important role in preparing for the oncology practices of tomorrow,” said Robert W. Carlson , MD, Chief Executive Officer, NCCN . “Past Young Investigator Awardees have gone on … Center, Duarte, CA ; Dana - Farber /Brigham and Women’s Cancer Center Massachusetts General Hospital Cancer Center, Boston, MA ; Duke Cancer Institute, Durham, NC ; Fox Chase Cancer Center, Philadelphia, PA ; Huntsman Cancer Institute at the University of …

National Comprehensive Cancer Network Working with Health Officials in Bolivia to Improve Cancer Care | PR Newswire | 4/24/2019

… guidelines in Bolivia; now they will be even more accessible and appropriate for optimizing treatment practices across the country,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “Working with local experts allows us to … Center, Duarte, CA; Dana-Farber/Brigham and Women’s Cancer Center Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of …

David King

David Ortiz undergoes third surgery for complications from gunshot wound - The Boston Globe | 7/11/2019

David Ortiz underwent a third surgery this week at Massachusetts General Hospital, where he continues to recover more than a month after a shooting ambush in the Dominican Republic, the retired Red Sox slugger’s wife … by the Red Sox. “The operation was performed by Dr. David King at Massachusetts General Hospital. David is recovering well and is in good spirits.” Emhoff, of UMass, said news of surgery is worrisome. “Usually

David Ortiz has had a third surgery for his gunshot wound, his wife says - CNN | 7/11/2019

CNN) Former Boston Red Sox player David Ortiz has had a third surgery, coming weeks after a gunman shot him in the back in his native Dominican Republic, his wife said in a statement Thursday. “Earlier this week, David underwent a third surgery for complications resulting from his gunshot wound,” Tiffany Ortiz said. “The operation was performed by Dr. David King at Massachusetts General Hospital. David is recovering well and …

Charlie Baker

While Baker is in London, criticism mounts over handling of RMV and MBTA - The Boston Globe | 6/26/2019

Governor Charlie Baker spent Wednesday promoting one of his administration’s top initiatives — offshore wind energy — kicking off four days of meetings, summits, and even a Red Sox-Yankees game during an official visit to London … Lauren, sponsored by Home Base, a veterans-focused partnership between Massachusetts General Hospital and the Red Sox Foundation. (Red Sox principal owner John Henry also owns the Globe.) On Saturday, Baker will attend the first

T to step up pace of Red Line signal repairs - The Boston Globe | 6/21/2019

… that we’re dealing with,” Wu said. Mayor Martin J. Walsh, who this week heavily criticized the T leadership under Governor Charlie Baker , wrote on Twitter that even though the T is making progress, “we need … for the class.” Katarzyna Franczak, who commutes to work at Massachusetts General Hospital from Quincy Adams, called the developments a “bummer.” She now spends around three hours each day on the T and even before …

Donald Trump

House’s surprise billing plan boosts state databases - POLITICO | 5/15/2019

… surprise-billing, in which patients unexpectedly receive a high bill from an out-of-network providers. There’s support from President Donald Trump and in Congress to end the practice, though there’s disagreements in the industry … their registration statement says . WHAT WE’RE CLICKING Vaccine opponents target Massachusetts General Hospital doctor on social media and online review sites. A company’s claims that its $330 thermometer can predict fertility was based on a …

Health care industry urges reprieve for Haitian immigrants - Houston Chronicle | 11/19/2017

Donald Trump’s administration weighs whether to extend temporary residency for thousands of Haitian immigrants by Thanksgiving. More than 30 providers wrote to the Department of Homeland Security Nov. 10 urging it to extend Temporary Protected Status, or TPS, for Haitian immigrants. Major institutions like Massachusetts General Hospital to smaller community-based health centers in Brockton, Lynn and elsewhere signed onto the letter. TPS allows immigrants to temporarily live and work …

Anne Klibanski

Celebrating the accomplishments of women leaders in healthcare | Modern Healthcare | 7/6/2019

Print Boston-based Partners HealthCare recently named its first female CEO , Dr. Anne Klibanski, to lead a system that includes world-renowned Massachusetts General Hospital and Brigham and Women’s Hospital. The American Medical Association continues to place women in its office of the president, including Dr. Barbara McAneny , immediate past president, and Dr. Patrice Harris , current president. All three were recognized this year by Modern Healthcare for being among the …

New Partners chief no stranger to role of uniter - The Boston Globe | 6/27/2019

As a physician at Massachusetts General Hospital in the 1980s, Dr. Anne Klibanski conceived of a new approach to help patients with pituitary gland disorders. She launched a clinic where a team of specialists — endocrinologists, neurologists, surgeons, and others — worked together to treat these patients. That experience of bringing together people with different backgrounds could turn out to be particularly valuable. Klibanski is the new chief executive of Mass. General’s …

Andrea Park

Partners HealthCare enrolls 100K patients in Biobank genetic research database | Becker’s Hospital Review | 7/9/2019

Partners HealthCare enrolls 100K patients in Biobank genetic research database Andrea Park - Print Email Partners HealthCare’s Biobank has surpassed 100,000 participants, making it one of the largest genetic databases in the U.S., the Boston-based … available to researchers and clinicians at Brigham and Women’s Hospital, Massachusetts General Hospital and other Partners institutions. The information in the database has so far been used in more than 200 studies, including ones focused

Brigham and Women’s, Emory and more join radiology AI pilot program | Becker’s Hospital Review | 6/26/2019

Brigham and Women’s, Emory and more join radiology AI pilot program Andrea Park - Print Email The American College of Radiology has recruited five more health systems to participate in a pilot program that will tailor … joined the ACR AI-LAB program. Previously announced participants include Massachusetts General Hospital in Boston and The Ohio State University in Columbus. Santa Clara, Calif.-based tech company Nvidia will provide its Clara AI software